Capturing Novel Non-opioid Pain Targets

Clifford J Woolf,Clifford J. Woolf

DOI: https://doi.org/10.1016/j.biopsych.2019.06.017

IF: 12.81

2020-01-01

Biological Psychiatry

Abstract:The relatively high efficacy of opioids for the management of acute and terminal pain, together with their addictive properties, tolerance and dependence, has been a major driver of the opioid crisis, through availability, over-prescription and diversion. Eliminating opioids without an effective replacement is, however, no solution, substituting one major problem with another. To deal successfully with the opioid crisis we need to discover novel analgesics without involvement of the mu opioid receptor but with high analgesic potency and low adverse effects, particularly no abuse liability. The question is how to achieve this? There are several necessary elements; first we need to understand the nature of and mechanisms responsible for pain, and second, we need to adopt novel and unbiased approaches to the identification and validation of pain targets.

neurosciences,psychiatry